Top Markets
#1 Akedo Akedo +59.54%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.99%
#4 Velvet Velvet +41.93%
#5 Black Phoenix Black Phoenix +34.52%
#6 τemplar τemplar +26.67%
#7 Ribbita by Virtuals Ribbita by Virtuals +18.08%
#8 Bitway Bitway +17.19%
#9 Cap Cap +17.11%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.52%
Coin of the day
Akedo Akedo
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Geffen Residence & Renewal Ltd Geffen Residence & Renewal Ltd

Geffen Residence & Renewal Ltd

GEFR
Classificação em ações #38275
Geffen Residence & Renewal Ltd, previously known as Cannomed Medical Cannabis... Geffen Residence & Renewal Ltd, previously known as Cannomed Medical Cannabis Industries Ltd, is a company with a dual focus based in Tel Aviv-Yafo, Israel, established in 1999. It plays a significant role in the Israeli medical cannabis market, overseeing the growth, manufacturing, storage, distribution, and retail of these products. Additionally, the company operates a chain of pharmacies that offer a wide array of merchandise. These retail outlets provide personal care items, cosmetics, and various convenience goods. Their pharmaceutical offerings include prescription and over-the-counter medications, alongside natural health products, vitamins, and supplements. The pharmacies also stock first-aid supplies like plasters and bandages, as well as health monitoring devices such as thermometers and humidifiers.
Preço da ação
$0.26456612
Valor de mercado
$1.09M
Variação (1 dia)
1.24%
Variação (1 ano)
13.83%
País
IL
Negociar Geffen Residence & Renewal Ltd (GEFR)

Categoria

Healthcare
Receita da Geffen Residence & Renewal Ltd (GEFR)
Receita em Aug 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Geffen Residence & Renewal Ltd, a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Geffen Residence & Renewal Ltd de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE